Michael Braun

This inventor holds 5 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Braun. Retrieved from https://idiyas.com/inventor/michael-braun-i3c51zsz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 6)

% Patents Active = 80.0

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 69(Granted Patents)

Location History:

Wullenstetten, DE (2015)
Senden, DE (2016 - 2021)

Company Filing History:

5 out of 1,562

Boehringer Ingelheim International Gmbh

patents

Years Active: 2015-2026

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12678442 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2026-07-14),

2. 10973827 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2021-04-13),

3. 10022379 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2018-07-17),

4. 9415016 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2016-08-16),

5. 9155705 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2015-10-13),

Title: Michael Braun: Innovator in Pharmaceutical Compositions

Introduction

Michael Braun is a notable inventor based in Senden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 5 patents to his name, Braun's work focuses on improving treatment options for patients with specific medical conditions.

Latest Patents

Among his latest patents, Braun has developed a DPP-IV inhibitor combined with a further antidiabetic agent. This invention includes tablets comprising such formulations, their use, and the process for their preparation. The present invention relates to pharmaceutical compositions that consist of fixed dose combinations of a DPP-4 inhibitor drug and a partner drug. These compositions are designed to treat certain diseases effectively.

Career Highlights

Throughout his career, Michael Braun has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim International GmbH and Riemser Specialty Production GmbH. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Braun has collaborated with several professionals in his field, including Thomas Friedl and Kenji Egusa. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceuticals.

Conclusion

Michael Braun's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective drug formulations. His work continues to impact the industry positively, paving the way for advancements in treatment options.

Profile summary based on public USPTO records.